宜宾方寸之间装饰工程有限公司
20-99人
公司优势
20,861+ 岗位更新等你来订阅
一键订阅最新的岗位，每周送达
🎉恭喜你，订阅成功
继续订阅您可以在邮箱中随时取消订阅
Visirna was founded in 2022 and has established a strategic partnership with Arrowhead Pharmaceuticals (NASDAQ: ARWR), a leading global company in small RNA drug development. The company currently has three clinical-stage siRNA drugs targeting cardiovascular and metabolic diseases. In addition, the company possesses independent R&D capabilities and is exploring liver-specific and extrahepatic delivery technologies, as well as broader therapeutic areas.
The company's current pipeline is at the forefront of its competitors, with targets supported by clear genomic and biological evidence, utilizing Arrowhead's validated delivery and chemical modification technology platforms. The company adopts a China-US collaborative clinical development and registration strategy to accelerate product commercialization.
The company's internal R&D capabilities will further enrich the clinical development pipeline in cardiovascular and metabolic diseases, promoting long-term sustainable development, while forming an integrated industry chain from R&D, production to sales through internal and external resources.
Visirna was founded in 2022 in a strategic partnership with Arrowhead Pharmaceuticals (NASDAQ: ARWR). Based in China, with a global vision, Visirna aims to be a leading player in the research and development of oligonucleotide therapeutics. We currently have three first-in-class late clinical-stage siRNA candidates licensed from Arrowhead Pharmaceuticals for the treatment of cardiovascular and metabolic diseases.
We are rapidly advancing our clinical pipelines in an array of trials. Currently we have one ongoing Phase 3 registration trial in FCS in China, and will soon join multiple MRCT trials for cardiovascular diseases. At the same time, we are also conducting a phase 2 PoC (proof of concept) trial in NASH.
Visirna is setting up a 1500 sqm R&D lab in Suzhou BioBAY to strengthen our existing clinical portfolio for cardiovascular and metabolic diseases. Our goal is to develop a comprehensive treatment repertoire that can effectively address the complex nature of these diseases and provide better outcomes for patients.
经营范围包括不干胶、医用双面胶带、保护膜制品的加工与销售及技术开发；塑料薄膜、绝缘材料、三色棉材料的加工与销售（以上危险品除外）；打印耗材及配件的加工与销售；五金标牌、包装盒、办公用品、金属制品、包装制品的销售。
江门好旺纺织有限公司，员工人数50至150人，企业性质为民营企业，所属行业为服装、纺织、皮革。
星梦想舞蹈培训中心总校区坐落于十堰市香格里拉精品街，成立于2012年6月，是一家专注于少儿拉丁舞和中国舞的培训机构。
星梦想舞蹈培训中心六里坪校区成立于2014年9月，是六里坪地区第二家专业舞蹈培训机构。
2015年4月18日，在参加北京舞蹈学院中国舞考级和武汉舞蹈学院拉丁舞考级中，均取得全优成绩。
2015年5月16日，参加由十堰市文化局和十堰市委宣传部主办的第12届柳林春晓少儿才艺大赛。
2015年6月20日，22名学员在十堰首届体育舞蹈邀请赛中分别荣获9金7银6铜的优异成绩。
四川兆信康科技公司诚聘英才